Valuation: PHARMAGEST INTER.

Market Cap 443M 500M 415M 376M 710M 48.16B 716M 4.98B 1.94B 24.57B 1.88B 1.83B 78.97B P/E 2026 *
9.94x
P/E 2027 * 8.95x
Enterprise Value 352M 396M 329M 298M 563M 38.2B 568M 3.95B 1.54B 19.49B 1.49B 1.46B 62.64B EV / Sales 2026 *
1.39x
EV / Sales 2027 * 1.2x
Free-Float
31.97%
Yield 2026 *
4.9%
Yield 2027 * 5.05%
Manager TitleAgeSince
Chief Executive Officer 57 22/04/2022
Director of Finance/CFO - 01/01/2023
Chief Tech/Sci/R&D Officer - 01/07/2018
Director TitleAgeSince
Chairman 61 25/06/2026
Director/Board Member 58 16/06/2011
Director/Board Member 57 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%+0.52%-23.59%+55.70% 209B
-2.27%-0.77%-9.04%+7.82% 189B
-0.89%+1.04%+61.03%+469.04% 128B
-0.86%+1.61%+38.39%+109.83% 119B
-0.38%+9.24%-22.03%-38.02% 116B
-0.68%+1.41%-27.63%-41.49% 79.43B
+1.38%+2.96%-25.76%-10.20% 58.33B
+4.94%+7.34%-31.09% - 48.2B
-0.25%+1.89%+15.04%+131.80% 44.61B
Average +0.04%+2.86%-2.74%+85.56% 110.24B
Weighted average by Cap. -0.55%+2.46%-1.33%+88.81%

Financials

2026 *2027 *
Net sales 254M 286M 238M 215M 407M 27.58B 410M 2.85B 1.11B 14.07B 1.07B 1.05B 45.22B 269M 303M 252M 228M 431M 29.2B 434M 3.02B 1.18B 14.9B 1.14B 1.11B 47.89B
Net income 44.1M 49.68M 41.27M 37.41M 70.64M 4.79B 71.16M 496M 193M 2.44B 186M 182M 7.85B 49.25M 55.48M 46.09M 41.77M 78.89M 5.35B 79.46M 554M 215M 2.73B 208M 204M 8.77B
Net Debt -91.7M -103M -85.81M -77.78M -147M -9.96B -148M -1.03B -401M -5.08B -388M -379M -16.33B -121M -136M -113M -102M -193M -13.1B -195M -1.36B -527M -6.68B -510M -499M -21.48B
Logo PHARMAGEST INTER.
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (72.8%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (15.9%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (6.2%): digital communication, telemedicine and telehealth solutions; - software publishing for private practitioners and medical assistants (4.2%); - development of financing solutions for leased goods (0.9%; Nanceo). Net sales are distributed geographically as follows: France (87.5%), Italy (6.1%), Belgium (3%), Germany (2.5%), the United Kingdom (0.8%), and Ireland (0.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - PHARMAGEST INTER.